Risperidone 2 mg Tablet

Adult dose

The therapeutic dose of this drug should be adjusted according to the patient's clinical condition, and the lowest effective dose possible should be administered. Place this drug on the tongue. Once it disintegrates within a few seconds, swallow it without water or with water (for orally disintegrating tablets only). 1. Schizophrenia 1) Adults (1) Initial dose: Administer risperidone 1 mg orally 2 times daily and increase the dose gradually. (2) Maintenance dose: Administer 1∼3 mg 2 times daily. Adjust the dose as appropriate according to age and symptoms. (3) No additional benefit was observed with doses of 10 mg or more per day compared with lower doses, and such doses may increase the risk of extrapyramidal symptoms. Doses of 10 mg or more per day should be administered only when the benefits for the individual patient are considered to outweigh the risks. (4) Do not administer doses of 16 mg or more per day, as safety has not been established. (5) A benzodiazepine may be administered concomitantly if additional sedation is needed. 2) Administration in specific populations · Elderly patients and patients predisposed to hypotension The initial dose is 0.5 mg 2 times daily. Depending on the patient's condition, increase the dose by 0.5 mg 2 times daily until reaching 1～2 mg 2 times daily. In general, increases to doses of 1.5 mg or more 2 times daily should be made at intervals of at least 1 week. 3) Switching from an existing antipsychotic to this drug When medically appropriate, initiate treatment with this drug while gradually reducing the dose of the existing drug. Also, when switching from an existing depot antipsychotic, when medically appropriate, initiate treatment with this drug in place of the next scheduled depot injection. Regularly reassess whether concomitant antiparkinsonian medication needs to be continued. 2. Agitation, aggression, or psychotic symptoms in patients with dementia of the Alzheimer type The initial dose is 0.25 mg of this drug 2 times daily. If necessary, depending on the patient, the dose may be increased by 0.25 mg per dose, 2 times daily, at intervals of at least 2 days. The optimal dose for most patients is 0.5 mg per dose, 2 times daily, but the dose may be increased to 1 mg per dose, 2 times daily, depending on the patient. Once the patient has reached the optimal dose, once-daily administration may also be considered. As with symptomatic treatment, the appropriateness of continued use of this drug should be evaluated. 3. Adjunctive treatment of mania in bipolar disorder · The recommended initial dose is 2 mg of this drug once daily. Depending on the patient, the dose may be increased by up to 1 mg per day at intervals of 24 hours or longer. The optimal dose for most patients is within the range of 2∼6 mg per day. As with symptomatic treatment, the appropriateness of continued use of this drug should be evaluated. Renal and hepatic impairment In patients with renal or hepatic impairment, administer half the initial and maintenance doses and adjust the dose more gradually. Use this drug with caution in these patients (see 5. General Precautions)

Child dose

Schizophrenia: There is insufficient clinical experience in children and adolescents under 15 years of age. Adjunctive treatment of mania in bipolar disorder: There is insufficient clinical experience in children and adolescents under 15 years of age. Disruptive behavior disorder and other disruptive behavior disorders - body weight 50 kg or more: The initial dose is 0.5 mg of this drug once daily. If necessary, depending on the patient, the dose may be increased by 0.5 mg per day at intervals of at least 2 days. The optimal dose for most patients is 1 mg once daily. Depending on the patient, 0.5∼1.5 mg may be administered once daily. Disruptive behavior disorder and other disruptive behavior disorders - body weight under 50 kg: The initial dose is 0.25 mg once daily. If necessary, depending on the patient, the dose may be increased by 0.25 mg per day at intervals of at least 2 days. The optimal dose for most patients is 0.5 mg once daily. Depending on the patient, 0.25∼0.75 mg may be administered once daily. Disruptive behavior disorder and other disruptive behavior disorders: As with symptomatic treatment, the appropriateness of continued use of this drug should be evaluated. Disruptive behavior disorder and other disruptive behavior disorders: There is insufficient clinical experience in children under 5 years of age.

This drug may increase mortality when administered to elderly patients with dementia, so caution is particularly important. Use of this drug in combination with the specific diuretic furosemide in elderly patients with dementia may further increase mortality risk, so the risks and benefits should be carefully considered before concomitant administration. Before taking this drug, it is important to identify risk factors for venous thromboembolism and take precautions for thrombosis prevention. This drug contains the artificial sweetener aspartame, so patients with certain genetic disorders like phenylketonuria should not take it. This drug should not be administered to individuals with certain allergies or hypersensitivity, patients in a central nervous system depressed state, patients in a coma, patients receiving epinephrine, or patients with lactose intolerance or related genetic disorders. Patients with cardiovascular disease or impaired liver and kidney function, patients with a history of seizures, patients with risk factors for diabetes, elderly patients, pregnant women, and nursing mothers should have dose adjustment and monitoring while using this drug, and caution is required. This drug may cause various side effects, such as drowsiness, dizziness, hypotension, Parkinsonism, movement disorders, gastrointestinal disturbances, weight gain, etc. If any unusual symptoms occur, consult a healthcare professional immediately. Additionally, caution is needed when this drug is used in conjunction with other central nervous system depressants, antihypertensives, and medications that prolong the QT interval, and using it with alcohol may enhance its central nervous system depressant effects. It is recommended that pregnant or nursing women do not take this medication, and women of childbearing potential should consult with a healthcare provider before taking it. In case of overdose, go to the hospital immediately for appropriate emergency care, as there is no antidote for this drug, supportive therapy based on symptoms is necessary. Finally, this drug should be kept out of reach of children, taken immediately after opening, and should not be mixed with tea, cola, or other substances.

Death, stroke, transient ischemic attack, venous thrombosis, pharyngitis, upper respiratory infection, sinusitis, urinary tract infection, anemia, hypersensitivity reactions, insomnia, anxiety, nervous hyperexcitability, Parkinson's syndrome, akathisia, drowsiness, dizziness, sedation, tremor, muscle rigidity, somnolence, orthostatic dizziness, dyskinesia, syncope, blurred vision, ear pain, orthostatic hypotension, tachycardia, hypotension, nasal congestion, dyspnea, epistaxis, sinus congestion, nausea, constipation, indigestion, vomiting, diarrhea, excessive salivation, dry mouth, abdominal discomfort, abdominal pain, gastrointestinal discomfort, epigastric pain, rash, dry skin, dandruff, seborrheic dermatitis, hyperkeratosis, back pain, arthralgia, limb pain, urinary incontinence, ejaculatory failure, fatigue, weakness, fever, chest pain, increased serum creatinine phosphokinase, increased heart rate, pneumonia, soft tissue infection, decreased appetite, altered mental state, transient ischemic attack, decreased consciousness, drooling, cerebrovascular accident, conjunctivitis, cough, runny nose, dysphagia, fecal impaction, erythema, abnormal posture, joint swelling, peripheral edema, gait disturbances, pitting edema, elevated body temperature, rhinitis, influenza, increased appetite, moderate insomnia, lethargy, headache, stuttering, attention deficit, balance disorders, excessive sleep, palpitations, pharyngo-laryngeal pain, pulmonary congestion, itching, acne, myalgia, neck pain, nocturnal enuresis, frequent urination, milk secretion, emotional disturbances, laziness, chest discomfort, weight gain, increased blood prolactin, agitation, attenuated affect, sleep disturbances, decreased libido, sexual dysfunction, depression, nightmares, unresponsiveness to stimuli, cooperation issues, loss of consciousness, speech disorders, sensory deficits, movement disorders, generalized dyskinesia, cerebral ischemia, cerebrovascular accident disorders, neuroleptic malignant syndrome, diabetic coma, head tremor, seizures, psychomotor hyperactivity, delayed dyskinesia, cerebrovascular disorders, sensory disturbances, conjunctival hyperemia, eye discharge, eye movements, eyelid edema, photophobia, eyelid crusting, dry eyes, increased tearing, glare, glaucoma, reduced vision, tinnitus, vertigo, bradycardia, tachycardia, palpitations, I degree AV block, left bundle branch block, right bundle branch block, AV block, flushing, conduction disturbances, abnormal ECG, prolonged QT interval on ECG, pulmonary embolism, bradycardia, wheezing, aspiration pneumonia, voice disorders, productive cough, airway congestion, rales, respiratory distress, nasal congestion, hyperventilation, fecal incontinence, gastritis, lip swelling, cheilitis, salivary deficiency, bloating, gastroenteritis, tongue swelling, toothache, skin discoloration, skin lesions, skin disorders, erythematous rash, papular rash, generalized rash, papulopustular rash, eczema, musculoskeletal chest pain, joint stiffness, muscle weakness, rhabdomyolysis, urination disorders, amenorrhea, gynecomastia, vaginal discharge, erectile dysfunction, ejaculation disorders, menstrual disorders, breast swelling, sexual dysfunction, retrograde ejaculation, breast secretion, thirst, influenza-like syndrome, edema, malaise, facial swelling, discomfort, generalized edema, chills, peripheral coldness, drug withdrawal syndrome, drug adverse reactions, decreased body temperature, procedure-related pain, increased ALT, abnormal ECG, eosinophilia, increased AST, leukopenia, elevated blood sugar, decreased hemoglobin, decreased hematocrit, hypothermia, decreased blood pressure, increased transaminases, increased gamma-glutamyl transferase, increased liver enzymes, agranulocytosis, thrombocytopenia, anaphylactic reaction, abnormal secretion of antidiuretic hormone, diabetic ketoacidosis, diabetes mellitus, hypoglycemia, water intoxication, mania, dysguesia, intraoperative iridoplegia syndrome, atrial fibrillation, deep vein thrombosis, pulmonary embolism, sleep apnea syndrome, intestinal obstruction, pancreatitis, jaundice, vascular edema, alopecia, neonatal drug withdrawal syndrome, urinary retention, priapism, hypothermia, chest pain, liver dysfunction, hepatitis, thirst, dry mouth, urinary retention, polyuria, pain, hiccups, increased sweating, urination disorders, leukopenia, arrhythmia, epistaxis, anemia, diarrhea, hangover, ocular movement seizures, acne, dysphagia, nocturia, tic disorder, dyspnea, suicidal ideation, cognitive disturbances, delusions, hallucinations, exacerbation of auditory symptoms, delayed movement disorders, hyperthermia, muscle rigidity, autonomic nervousness, consciousness disorders, elevated serum creatine phosphokinase, myoglobinuria, acute renal failure, confusion, insensitivity, postural instability, falls, hyperglycemia, worsening of diabetes, weight gain, falls, priapism, orthostatic hypotension, syncope, decreased deep body temperature

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Furthermore, to maintain the drug's effectiveness, it is important to store it at room temperature, between 1 degree and 30 degrees Celsius.

Appearance

Oblong light orange film-coated tablets

Package unit

30 tablets/bottle, 200 tablets/bottle